Association between prehypertension, metabolic and inflammatory markers, decreased adiponectin and enhanced insulinemia in obese subjects

Table 1 Subject’s general clinical characteristics for obese and lean groups

	Control	n	Normoinsulinemic	n	Hyperinsulinemic	n	p	p¹	p²	p³
	(LS)		(NI)		(HI)			LSvs. NI	LSvs. HI	NIvs. HI
M/F*	4/9	13	2/13	15	5/7	12	ns	-	-	-
Age (years)	33 ± 12	13	29 ± 7	15	29 ± 8	12	ns	ns	ns	ns
Body mass (Kg)	63.71 ± 8.98	13	95.67 ± 12.78	15	103.464 ± 12.89	12	0.0001	0.0001	0.0001	ns
Height (m)	1.66 ± 0.10	13	1.63 ± 0.09	15	1.69 ± 0.09	12	ns	ns	ns	ns
BMI (kg/m²)	22.92 ± 2.03	13	35.25 ± 3.80	15	37.05 ± 3.88	12	0.0001	0.000	0.0001	ns
Fat mass (kg)	18.66 ± 3.98	13	36.70 ± 7.15	15	40.80 ± 9.24	12	0.0001	0.0001	0.0001	ns
Lean mass (kg)	41.49 ± 6.02	13	57.22 ± 8.02	15	63.76 ± 10.12	12	0.0001	0.0001	0.0001	ns
Body water (%)	48.77 ± 4.98	13	41.34 ± 5.16	15	42.04 ± 4.72	12	0.006	0.004	0.008	ns
Basal metabolic rate (kcal)	1261.3 ± 183.53	13	1740 ± 244.07	15	1938.45 ± 307.62	12	0.0001	0.000	0.0001	ns

M/F male/female; BMI body mass index; Values are means ± DP; P values for comparison between groups by non-parametric analysis of Kruskal Wallis; *P values for comparison between groups by non-parametric analysis descriptive of Chi-Square; P, comparing all groups. P¹, P² and P³ comparison between groups.